Precision Medicine Platforms
Part of Healthcare - Genomics & Precision Medicine
 AZN | AstraZeneca PLC | $250.7b | $163.82 | +0.6% | 2.6M |
 TMO | Thermo Fisher Scientific, Inc. | $228.7b | $647.92 | +1.1% | 2.3M |
 DHR | Danaher Corporation | $147.6b | $208.43 | -0.2% | 2.9M |
 WAT | Waters Corp | $40.6b | $416.80 | +0.4% | 522.3K |
 GH | Guardant Health, Inc. Common Stock | $21.9b | $173.98 | -0.4% | 1.3M |
 BBIO | BridgeBio Pharma, Inc. Common Stock | $15.0b | $68.34 | -0.1% | 2.8M |
 RVTY | Revvity, Inc. | $14.6b | $147.34 | +3.8% | 2.9M |
 TEM | Tempus AI, Inc. Class A Common Stock | $11.7b | $69.78 | +1.6% | 7.1M |
 TECH | Bio-Techne Corp. | $11.4b | $72.30 | -0.0% | 3.3M |
 PRAX | Praxis Precision Medicines, Inc. Common Stock | $9.9b | $310.68 | -1.3% | 495.3K |
 KYMR | Kymera Therapeutics, Inc. Common Stock | $9.9b | $116.31 | +2.9% | 520.8K |
 NUVL | Nuvalent, Inc. Class A Common Stock | $9.8b | $123.96 | 0.0% | N/A |
 TWST | Twist Bioscience Corporation Common Stock | $8.5b | $142.90 | +3.6% | 2.2M |
 CAI | Caris Life Sciences, Inc. Common Stock | $7.0b | $28.20 | -1.1% | 3.8M |
 LNTH | Lantheus Holdings, Inc | $6.6b | $100.58 | -0.2% | 444.6K |
 DYN | Dyne Therapeutics, Inc. Common Stock | $4.7b | $17.89 | -3.3% | 1.9M |
 ADPT | Adaptive Biotechnologies Corporation Common Stock | $3.9b | $28.21 | +3.8% | 4.4M |
 IDYA | IDEAYA Biosciences, Inc. Common Stock | $3.9b | $38.01 | +0.1% | 461.3K |
 WGS | GeneDx Holdings Corp. Class A Common Stock | $2.6b | $97.39 | +2.9% | 653.8K |
 CDNA | CareDx, Inc. | $2.6b | $53.69 | +1.7% | 725.7K |
 ANRO | Alto Neuroscience Inc. | $1.4b | $29.98 | -0.8% | 399.1K |
 MAZE | Maze Therapeutics, Inc. Common Stock | $1.4b | $23.91 | -1.5% | 314.6K |
 CSTL | Castle Biosciences, Inc. Common Stock | $1.0b | $35.48 | -0.6% | 406.8K |
 NVCT | Nuvectis Pharma, Inc. Common Stock | $0.8b | $21.87 | -0.3% | 111.1K |
 AURA | Aura Biosciences, Inc. Common Stock | $0.8b | $6.72 | -2.7% | 1.1M |
 SOPH | SOPHiA GENETICS SA Ordinary Shares | $0.7b | $7.97 | +0.5% | 1.5M |
 OABI | OmniAb, Inc. Common Stock | $0.7b | $4.34 | 0.0% | 827.1K |
 CTKB | Cytek Biosciences, Inc. Common Stock | $0.6b | $4.93 | +0.8% | 1.3M |
 PRLD | Prelude Therapeutics Incorporated | $419.0m | $4.47 | -0.9% | 156.1K |
 FHTX | Foghorn Therapeutics Inc. Common Stock | $307.0m | $4.16 | +1.6% | 295.6K |
 BDSX | Biodesix, Inc. Common Stock | $286.6m | $28.55 | +2.6% | 96.0K |
 ACIU | AC Immune SA | $282.4m | $2.66 | -0.7% | 116.3K |
 AVXL | Anavex Life Sciences | $267.9m | $2.37 | -3.3% | 799.5K |
 LAB | Standard BioTools Inc. Common Stock | $264.3m | $0.71 | +4.2% | 845.6K |
 XGN | Exagen Inc. Common Stock | $182.7m | $7.78 | +3.9% | 275.4K |
 QSI | Quantum-Si Incorporated Class A Common Stock | $166.6m | $0.75 | +3.4% | 857.2K |
 QTRX | Quanterix Corporation Common Stock | $122.0m | $2.90 | +7.0% | 861.7K |
 NAUT | Nautilus Biotechnolgy, Inc. Common Stock | $117.0m | $0.98 | +9.1% | 1.1M |
 SEER | Seer, Inc. Class A Common Stock | $107.4m | $1.91 | +1.1% | 141.6K |
 ACRV | Acrivon Therapeutics, Inc. Common Stock | $92.1m | $1.71 | -6.6% | 604.1K |
 IBIO | iBio, Inc. Common Stock | $84.2m | $1.19 | 0.0% | 340.8K |
 SERA | Sera Prognostics, Inc. Class A Common Stock | $78.1m | $2.03 | +1.5% | 5.3K |
 CSBR | Champions Oncology, Inc. | $71.7m | $5.03 | +3.8% | 30.5K |
 MDXH | MDxHealth SA Ordinary Shares | $69.3m | $0.65 | +0.6% | 132.2K |
 TVGN | Tevogen Inc. Common Stock | $46.7m | $7.67 | 0.0% | 2.6K |
 CCEL | Cryo-Cell International Inc. | $32.6m | $4.41 | +0.7% | 14.5K |
 ALLR | Allarity Therapeutics, Inc. Common Stock | $22.4m | $1.18 | +3.6% | 50.6K |
 ADVB | Advanced Biomed Inc. Common Stock | $16.1m | $7.75 | 0.0% | 12.5K |
 CDIO | Cardio Diagnostics Holdings Inc. Common stock | $5.4m | $2.00 | +1.5% | 32.1K |